The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate β-amyloid(25–35) induced neurodegeneration in cultured hippocampal neurons
Abstract
beta-Amyloid peptide has been reported to be toxic to neurons in vitro and in vivo. The fragment of the beta 1-42 peptide believed to be responsible for this toxicity consists of amino acids 25 to 35. beta-amyloid protein, heparan sulfate (HS) glycosaminoglycan (GAG), and proteoglycan (PG) are all localized throughout the senile plaques found in Alzheimer's disease. Chondroitin sulfate (CS) and dermatan sulfate have also been found at the periphery of senile plaques. We have found that both HS and CS prevented neurite fragmentation and toxicity normally induced by beta 25-35. HS and CS by themselves did not have a significant influence on cell viability, indicating that their protective actions were not due to a general trophic effect. In contrast, cultures treated with HS and beta 1-42 did not show significantly reduced toxicity compared to cultures treated with beta 1-42 alone despite specific binding interactions. These data indicate that one function of GAGs in the brain may be to protect neurons from select toxic insults and injury, and additionally suggest that HS interacts differently with different beta-amyloid fragments. These data further suggest that different beta-amyloid fragments may induce distinct mechanisms of toxicity in vitro.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have demonstrated that heparin and heparin sulphate suppress Aβ cellular toxicity (Woods et al., 1995; Bergamaschini et al., 2002), likely by inhibiting cellular Aβ binding and/or uptake.”
From Heparan Sulphate Proteoglycan and the Low-Density Lipoprotein Receptor-Related Protein 1 Constitute Major Pathways for Neuronal Amyloid-β Uptake (2011) · cites this paper as Woods et al., 1995
Citations
Cites
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Self-citationβ-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology
Pike, C. J., Cummings, B. J., & Cotman, C. W. (1992) · Neuroreport · doi:10.1097/00001756-199209000-00012 · Cited by 131
Self-citation
Research works printed but not linked: 40
- Behl, 1994, Hydrogen peroxide mediates amyloid β protein toxicity, Cell, 77, 817, 10.1016/0092-8674(94)90131-7 · DOI · Paper page
- Brunden, 1993, pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans, J. Neurochem., 61, 2147, 10.1111/j.1471-4159.1993.tb07453.x · DOI · Paper page
- Buee, 1993, Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide, Brain Res., 601, 154, 10.1016/0006-8993(93)91706-X · DOI
- Copani, 1991, Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation, Neuroreport, 2, 763, 10.1097/00001756-199112000-00008 · DOI
- Cummings, 1993, β-Amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease, Neurobiol. Aging, 14, 547, 10.1016/0197-4580(93)90038-D · DOI
- DeWitt, 1993, Chondroitin-sulfate proteoglycans are associated with the lesions of Alzheimer's disease, Exp. Neurol., 121, 149, 10.1006/exnr.1993.1081 · DOI
- Fraser, 1992, Effects of sulfate ions on amyloid β/A4 assemblies: implications for amyloid fibril-proteoglycan interactions, J. Neurochem., 59, 1531, 10.1111/j.1471-4159.1992.tb08470.x · DOI
- Grant, 1987, Pericellular heparans may contribute to the protection of cells from free radicals, Med. Hypotheses, 23, 67, 10.1016/0306-9877(87)90183-6 · DOI
- Hansen, 1989, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill, J. Immunol. Methods, 119, 203, 10.1016/0022-1759(89)90397-9 · DOI
- Karlsson, 1988, Binding of human extracellular-superoxide dismutase C to sulphated glycosaminoglycans, Biochem. J., 256, 29, 10.1042/bj2560029 · DOI
- Karlsson, 1989, Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells, Lab. Invest., 60, 659
- Klagsburn, 1989, The fibroblast growth factor family: structural and biological properties, Prog. Growth Factor Res., 1, 207, 10.1016/0955-2235(89)90012-4 · DOI
- Koh, 1990, Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage, Brain Res., 533, 315, 10.1016/0006-8993(90)91355-K · DOI
- Kowall, 1992, In vivo neurotoxicity of beta-amyloid [beta(1–40)] and the beta(25–35) fragment, Neurobiol. Aging, 13, 537, 10.1016/0197-4580(92)90053-Z · DOI
- Lander, 1982, Characterization of a factor that promotes neurite outgrowth: evidence linking activity to a heparan sulfate proteoglycan, J. Cell Biol., 94, 574, 10.1083/jcb.94.3.574 · DOI
- Ledoux, 1992, Interactions of FGFs with target cells, Prog. Growth Factor Res., 4, 107, 10.1016/0955-2235(92)90026-E · DOI
- Leveugle, 1994, Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic sulfated compounds, NeuroReport, 5, 1389
- Mattson, 1992, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12, 376, 10.1523/JNEUROSCI.12-02-00376.1992 · DOI
- Mattson, 1993, Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF, Brain Res., 621, 35, 10.1016/0006-8993(93)90295-X · DOI
- Narindrasorasak, 1991, High affinity interactions between the Alzheimer's β-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan, J. Biol. Chem., 20, 12878, 10.1016/S0021-9258(18)98776-4 · DOI
- Perlmutter, 1990, Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease, Brain Res., 508, 13, 10.1016/0006-8993(90)91111-S · DOI
- Perry, 1991, The association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease, J. Neurosci., 11, 3679, 10.1523/JNEUROSCI.11-11-03679.1991 · DOI
- Pike, 1993, Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13, 1676, 10.1523/JNEUROSCI.13-04-01676.1993 · DOI · Paper page
- Pike, 1991, In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res., 563, 311, 10.1016/0006-8993(91)91553-D · DOI
- Pollack, 1995, Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells, Neurosci. Lett., 184, 113, 10.1016/0304-3940(94)11182-I · DOI
- Schubert, 1987, Multiple influences of a heparin-binding growth factor on neuronal development, J. Cell Biol., 104, 635, 10.1083/jcb.104.3.635 · DOI
- Simmons, 1994, Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol., 45, 373
- Snow, 1985, Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study, Lab Invest., 53, 37
- Snow, 1988, The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease, Am. J. Pathol., 133, 456
- Snow, 1989, A characteristic binding affinity between heparan sulfate proteoglycans and the A4 amyloid protein of Alzheimer's disease, J. Neuropathol. Exp. Neurol., 48, 352, 10.1097/00005072-198905000-00160 · DOI
- Snow, 1990, Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome, Am. J. Pathol., 137, 1253
- Snow, 1987, Sulfated glycosaminoglycans in Alzheimer's disease, Hum. Pathol., 18, 506, 10.1016/S0046-8177(87)80036-9 · DOI
- Snow, 1992, Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease, J. Histochem. Cytochem., 40, 105, 10.1177/40.1.1370306 · DOI
- Snow, 1987, Sulfated glycoaminoglycans: a common constituent of all amyloids?, Lab Invest., 56, 120
- Su, 1992, Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease, Neuroscience, 51, 801, 10.1016/0306-4522(92)90521-3 · DOI
- Terry, 1983, Senile dementia of the Alzheimer's type, Ann. Neurol., 14, 497, 10.1002/ana.410140502 · DOI
- Walicke, 1988, Interactions between basic fibroblast growth factor (FGF) and glycosaminoglycans in promoting neurite outgrowth, Exp. Neurol., 102, 144, 10.1016/0014-4886(88)90087-8 · DOI
- Walicke, 1991, Internalization and processing of basic fibroblast growth factor by neurons and astrocytes, J. Neurosci., 11, 2249, 10.1523/JNEUROSCI.11-07-02249.1991 · DOI
- Whittemore, 1994, Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons, Neuroreport, 5, 1485, 10.1097/00001756-199407000-00019 · DOI
- Yankner, 1989, Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease, Science, 245, 417, 10.1126/science.2474201 · DOI · Paper page
Cited by
Sorted by citations
Kanekiyo, T., Zhang, J., Liu, Q., Liu, C.-C., Zhang, L., & Bu, G. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-10.2011 · Cited by 212
Metadata
- Authors
- Woods, A. G., Cribbs, D. H., Whittemore, E. R., & Cotman, C. W.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1995-10
- Volume
- 697
- Issue
- 1-2
- Pages
- 53-62
- ISSN
- 0006-8993
- Cited by
- 56
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review